Gamma-interferon-1b (** Actimmune (generic: interferon gamma-1b) **)
Other Medications
Description
Interferon gamma-1b is not commonly used as a first-line treatment for colorectal cancer. Its use in oncology is primarily experimental or off-label, often involving immune modulation rather than direct cytotoxic effects on tumor cells.
Mechanism of Action
Interferon gamma-1b is a cytokine that activates immune cells and enhances the expression of major histocompatibility complex (MHC) molecules, promoting an antitumor response.
Side Effects
Anemia; neutropenia; flu-like symptoms; fatigue; myalgia; arthralgia;
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT00786643
Phase 2
Archived
Study of Gamma Interfereon in Metastatic Colorectal Carcinoma
United States
Quick Info
| Brand Name | ** Actimmune (generic: interferon gamma-1b) ** |
| Category | Other Medications |
 EMA Status | Not submitted to EMA |
 Spain Access | Not funded |
| Clinical Trials | 1 |
Related Medications
Uracil
Other Medications
786 trials
Leucovorin
Other Medications
647 trials
Paclitaxel
Other Medications
54 trials
Trifluridine
Other Medications
50 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.